# FDA Inspection 1163074 - American National Red Cross (The) - February 11, 2022

Source: https://www.keypedia.com/records/fda_inspections/american-national-red-cross-the/539463c0-8e7f-4fa6-b708-50d09e08d129
Source feed: FDA_Inspections

> FDA Inspection 1163074 for American National Red Cross (The) on February 11, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1163074
- Company Name: American National Red Cross (The)
- Inspection Date: 2022-02-11
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1295548 - 2025-12-09](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-the/f5d36727-7dc0-4df9-b437-1609618f1290)
- [FDA Inspection 1295548 - 2025-12-09](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-the/3f17b60f-5ab6-4b45-8e8d-f6797a492222)
- [FDA Inspection 1163074 - 2022-02-11](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-the/d58163d0-ffef-40f9-938c-b15ddfd992be)

Company: https://www.keypedia.com/companies/american-national-red-cross-the/cdf67aae-f02e-4dce-9aa2-64575f961722

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d